MarketInOut Stock Screener Log In | Sign Up

AbbVie Inc

XETRA • Healthcare • Drug Manufacturers - General • Quote as of 10/30/2026
AbbVie Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization468,463 mln
Float1,765 mln
Earnings Date10/29/2026

EPS

3.03
Stretched

P / E

87.49
Speculative

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.86
Likely reliable

Relative Strength

90 / 100
Top performer

Pre-Tax Margin

14%
Moderate margin

Business Description

AbbVie is a global medicines company that develops, manufactures, and sells treatments across a wide range of health conditions, including cancer, autoimmune and inflammatory diseases, neurological disorders, and eye care. Its portfolio includes well-known products such as Skyrizi, Rinvoq, Imbruvica, and Botox, among many others. Founded in 2012 and based in North Chicago, Illinois, the company operates worldwide and continues to invest heavily in research to bring new therapies to patients.

Key Fundamentals

EPS3.03
P/E87.49
ROE-224
RPS33.30
ROIC14.21
ROA4.66
Interest Cover7.13
EBITDA, mln16,898
EV / EBITDA29.78
EV / EBIT49.76
Revenue, mln55,213
EV / Revenue9.11

Quote Details

Last 265.10
Change 6.9 (2.67%)
Open 265.10
Volume 1,094
Turnover 290,019
Average Volume 533.52

Financial Ratios

Pre-Tax Profit Margin14
Current Ratio0.81
Price / Cash Flow26.79
Price / Free Cash Flow28.71
Price / Sales8.12
PEG Ratio0.59

Financial Strength

Altman Z-Score2.73
Piotroski F-Score 8 / 9
Beneish M-Score-2.86
Price to Intrinsic Value2.89
Shiller PE Ratio61.22

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.21% 92 / 100   
1 Month 15.06% 95 / 100   
2 Months 14.96% 93 / 100   
6 Months 55.82% 98 / 100   
1 Year 44.48% 93 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog